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An antiparallel strand arrangement in water-soluble helicates creates an amphipathic functional topology akin to 
that of host-defence peptides. High and selective cancer cell line toxicity is exhibited, causing dramatic 
changes in the cell cycle without DNA damage, and remarkably there is no significant toxicity to MRSA and 
E. coli. 
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Abstract  
Small cationic amphiphilic -helical peptides are emerging as agents for the treatment of cancer and 
infection, but they are costly and display unfavourable pharmacokinetics. Helical coordination 
complexes may offer a three-dimensional scaffold for the synthesis of mimetic architectures; 
however, the high symmetry and modest functionality of current systems offer little scope to tailor the 
structure to interact with specific biolomolecular targets, or to create libraries for phenotypic screens. 
Here we report the highly stereoselective asymmetric self-assembly of very stable, functionalised 
metallohelices.  Their anti-parallel Head-to-Head-to-Tail ‘triplex’ strand arrangement creates an 
amphipathic functional topology akin to that of the active sub-units of e.g. host-defence peptides and 
p53. The metallohelices display high, structure-dependent toxicity to the human colon carcinoma cell-
line HCT116 p53++ causing dramatic changes in the cell cycle without DNA damage. They have 
lower toxicity to human breast adenocarcinoma cells (MDA-MB-468), and most remarkably they 
show no significant toxicity to the bacteria MRSA and E. coli.  
150 words 
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The active regions of many disease-resisting proteins – such as the human antimicrobial host-defence 
peptide cathelicidin LL-371 and p532 which prevents mutations in the genome – are based around a 
cationic amphipathic -helix. Correspondingly, these small units have been investigated as clinical 
antibiotic and anticancer compounds.3-6 Significant progress has also been made in the development 
of synthetic derivatives with greater structural integrity, such as stapled peptides, 7,8 and peptidic 
foldamers based on unnatural building blocks.9-11 In addition, several non-peptide synthetic scaffolds 
have been put forward12,13 in an effort to provide synthetically tractable systems while still presenting 
key recognition features of the -helix.  
 
Fig 1 | Metallohelix architectures. Metal helicates are usually based on rigid ditopic bidentate ligands AB–BA giving – at octahedral 
centres – D3-symmetric enantiomers [M2(AB–BA)3] (a), while the use of directional ligands AB–CD leads to mixtures of C3-symmetric 
Head-to-Head-to-Head (b) and C1-symmetric Head-to-Head-to-Tail “triplex” architectures (c). A highly stereoselective approach to this 
latter architecture has now been designed and realised. Computational investigations showed that -stacking phenomena in stereogenic units 
of type (d) based on L1 were modulated by introducing bpy units as in (e). A series of L1–bpy (i.e. AB–CD) ditopic ligands such as L2a and 
L3a (f) were subsequently used to make a library of triplex metallohelices.  
Certain self-assembling multimetallic coordination complexes, known as helicates14 [Fig 
1(a)], resemble -helices in terms of their diameter and charge, but since they are synthesised using 
symmetric rigid ligands AB–BA they have much higher symmetry. When directional ligands AB–CD 
are employed, Head-to-Head-to-Head [HHH, Fig. 1(b)] and Head-to-Head-to-Tail [HHT, (c)] 
constitutions are introduced, and a total of four pairs of enantiomers [M2(AB–CD)3] are possible. 
Correspondingly, these architectures are observed in mixtures of stereo- and/or optical isomers.15-22 
Also, most helicates contain little if any external functionality, are incompatible with water, and are 
not readily available in enantiomerically pure form.23 For example, a prototypical [M2(AB–BA)3] 
system24 for which several biological studies have been reported25-27 is based on few analogues, 
requires chromatographic resolution or lengthy syntheses, and undergoes significant hydrolysis on 
4 
 
experimental timescales (vide infra).  Thus, although helicates are appealing as a potential framework 
for peptidomimetic chemistry, they cannot currently provide us with anything approaching the 
exquisite functionality and topography present in natural -helix systems. 
Recently we showed that by linking two diastereomerically pure tris-chelate metal complex 
units28-31 via the groups X [Fig 1(d)] we could access water-compatible, stereochemically inert, 
functionalised helices we called flexicates.32,33 These compounds are highly symmetrical, with the 
general structure of Fig1(a). We previously established that the very high stereoselection ( v. ) in 
the monometallics arises largely from steric effects, while the arene -interactions shown are 
principally responsible for fac/mer selectivity and the unusual stability of flexicates in water.28  Since 
the mer configurations cannot be present in a helicate-like structure in any event we reasoned that -
stacking effects might be exploited to deliver stereoselection for the desirable, asymmetric HHT 
isomers of [M2(AB–CD)3] while still retaining control over helicity. Here we report a highly 
stereoselective self-assembly of diverse, stable, functionalised, metallohelices with anti-parallel 
‘triplex’ arrangement of strands. These metallohelices have amphipathic topology and very high, 
structure-dependent, selective biological activity. As such we believe that these triplex metallohelices 
represent a new and versatile -helix mimetic structure type.  
Results 
Design, synthesis and characterisation 
We considered a directional ditopic ligand design AB–CD where AB– is provided by a derivative of 
L
1 [Fig 1], and –CD comes from an achiral bidentate; here we chose 2,2'-bipyridine (bpy) because it 
is expected to form strong intramolecular -stacks with co-ligands L1 but not with itself, and also 
since a large number of derivatives are known. The feasibility of a diastereoselective HHT isomer 
synthesis using putative new helicands such as L2a and L3a was assessed first by computing the 
relative energies of individual metal units expected in that architecture (Table 1, entries 1-4).  
For [FeL12(bpy)]
2+ six isomers are possible, but only the - and -cis,cis diastereomers have 
the appropriate connectivity to be present in the HHT structure. Of these, the  diastereomer [depicted 
in Fig 1(e)] was found to be the more stable by 9.62 kcal mol-1 due to a strong steric clash involving 
methyl groups in the Λ isomers. Additionally, both isomers feature one parallel-offset π-stacking 
interaction34 between a metal-coordinated pyridine ring and the neighbouring L1 ligand, and a second 
interaction between L1 and bpy. Grimme has noted that the magnitude of such interactions increases 
with the number of rings involved.35  
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For the doubly bpy-substituted unit [FeL1(bpy)2]
2+
 the two possible isomers are C1 symmetric 
diastereomers. Both contain a parallel-offset π-stacking interaction between the phenyl ring and an 
adjacent bpy ligand, but sterics again dictate that the Δ enantiomer is the lower in energy, this time by 
2.58 kcal mol-1 (entry 4).  We conclude that the presence of one or two L1-type ligands is sufficient to 
deliver stereocontrol at a single metal centre, and thus that a HHT structure [Fig 1(c)] in this series is 
likely to be homochiral, i.e. have the same absolute configuration at both metal centres. 
Entry Complex isomer Relative energy 
kcal mol
-1
 
Population/% 
(298 K) 
1 
cis,cis,SC-[FeL
1
2(bpy)]
2+ 
SC,ΔFe 0.0 - 
2 SC,Fe +9.62 - 
3 
SC-[FeL
1(bpy)2]
2+ 
SC,ΔFe  0.0 - 
4 SC,Fe +2.58 - 
5 
[Zn2L
2a
3] 
SC,∆,∆,HHT 0.00 93.8 
6 SC,∆,∆,HHH +0.95 6.2 
7 SC,∆,,HHT +4.66 0.0 
8 SC,∆,,HHH +6.48 0.0 
9 
[Fe2L
2a
3] 
SC,∆,∆,HHT 0.00 97.4 
10 SC,∆,∆,HHH +1.51 2.6 
11 SC,∆,,HHH +7.62 0.00 
12 SC,∆,,HHT +8.82 0.00 
13 
[Zn2L
3a
3] 
RC,∆,∆,HHT 0.00 99.8 
14 RC,∆,∆,HHH +3.05 0.2 
15 RC,∆,,HHH +4.11 0.0 
16 RC,,,HHT +10.39 0.0 
17 
[Fe2L
3a
3] 
RC,∆,∆,HHT 0.00 99.5 
18 RC,∆,∆,HHH +2.50 0.5 
19 RC,∆,,HHH +12.55 0.0 
20 RC,∆,,HHT +17.64 0.0 
Table 1 | Calculated energies (DFT) of selected isomers for monometallic units and metallohelices. In the stereochemical 
descriptors, subscripts  and  refer to the pyridineimine-rich and bpy-rich metal centres respectively. The equilibrium selectivities were 
determined the statistically corrected energies of each isomer at 298 K. 
The potential effects of helication and the thermodynamic selectivity HHT vs HHH were then 
investigated for both Zn(II) and Fe(II) with L2a and L3a: ligands for which reasonable synthetic routes 
were envisaged and a large number of derivatives are possible (vide infra). For the particular carbon-
centred configurations used here, the homochiral (,) HHT isomers were found to be the lowest 
energy by between 0.95 and 3.05 Kcal mol-1 (Table 1, entries 5, 9, 13, 17), followed by the 
corresponding HHH. The effect of helication is also apparent; the homochiral HHH isomers are more 
stable than the corresponding mesocate-like structures (entry 6 v 8 etc). Following a correction for the 
fact that each HHT structure can be formed in three ligand permutations compared with only one for 
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each HHH, the estimated equilibrium selectivities for the asymmetric helicate are excellent, 
particularly for L3. 
 
 
 
 
Fig 2 | Synthesis and characterisation of triplex metallohelices. (a) Self-assembly from versatile components of a wide range of 
functionalised helices in which the strands are arranged head-head-tail; (b) 1H NMR spectrum and key assignments for RC,∆Zn,HHT-
[Zn2L
3a
3][ClO4]4. The small singlet at 8.76 ppm may be due to the three spectroscopically equivalent imine protons in the C3-symmetric 
HHH isomer. On this assumption the diastereomeric purity is >98%; (c) space-filling model of the cationic unit in RC,∆Zn,HHT-
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[Zn2L
3b
3][ClO4]4 from X-ray crystallography viewed along the Zn-Zn axis, showing the somewhat flattened architecture, and (d) rotated left 
by 90°. The three OH groups surround the basal plane while the upper ridge is comprised of -stacked arenes.  
The new compounds 2 and 3 were combined with a selection of metal sources, plus aldehydes or 
phenethylamines as shown in Fig 2 in one-pot reactions to give the two ranges of homochiral helicates 
shown. By analogy with the bi-directional motif of triplex DNA, we refer to these as triplex 
metallohelices. The compounds were characterised by NMR spectroscopy, mass spectrometry, 
UV/vis, circular dichroism, IR, thermogravimetry and microanalysis. For example, mixing three 
equivalents each of amine R-3 and 2-pyridinecarboxaldehyde with two equivalents of 
Zn(ClO4)2·6H2O led to the clean formation of RC,∆Zn,HHT-[Zn2L3a3][ClO4]4. The 1H NMR spectrum 
of this complex [Fig 1(b)] indicates the presence of three spectrocopically unique ligand 
environments. Of particular interest is that two of the bpy atoms Hb are observed at unusually low 
field (ca 9.2 ppm). We propose that this results from the close proximity (ca 2.5 Å) of these protons to 
the ether oxygen atom of an adjacent ligand as observed in the computed structure and as indicated in 
Figure 1(a). No such interaction is observed for the remaining Hb, the resonance being observed 
further up field at 8.41 ppm. Similarly, two sets of phenyl ring protons Hd and He (6.65-5.85 ppm) 
experience strong through-space shielding from the bpy unit of an adjacent ligand. These observations 
indicate that the solution structure corresponds very closely to that computed above. Overall, the 
equilibrium selectivity for the isomer shown is exceptionally good (>98%) and consistent with 
calculation (99.8% Table 1).  
 In the case of RC,∆Zn,HHT-[Zn2L3b3][ClO4]4 very small needle like crystals were obtained by 
slow vapour diffusion of ethyl acetate into a solution of the compound in acetonitrile/methanol. An X-
ray diffraction study confirmed the homochiral (∆Zn) HHT structure depicted in Figure 2(a), (c) and 
(d). The single “conventional” phenyl/pyridine -stack has a centroid–centroid distance of ca 3.60 Å, 
within the range we have reported previously.28 The two -stacks between phenyl and 2,2'-bipyridine 
rings may be described by two such centroid-centroid distances: a shorter at 3.60-3.69 Å and a longer 
of 4.41-4.60 Å. The rings are close to parallel (ca 5˚) with interplanar distances of ca 3.38 Å, 
significantly shorter than those computed by Grimme for similar scenarios (ca 3.5 Å).35 This may be 
due to the greatly increased polarity caused by coordination of the biaryl to the metal. The two cross-
strand bpy-HO interactions noted above are also observed (ca 2.5 Å). For the overall structure, and 
unlike conventional helicate systems, the triplex assembly leads to a slightly flattened structure [Fig 
2(b),(c)] and pronounced asymmetry of functional group placement; a basal region contains the three 
hydroxyl groups and the structure narrows to a hydrophobic ridge comprising five -stacked rings.   
 
Water soluble triplex metallohelices were obtained using the above self-assembly reactions 
and iron(II) chloride. 1H-NMR spectra were broadened in comparison with the Zn(II) systems but 
8 
 
well resolved and fully assigned 13C spectra were obtained. Microanalysis, thermogravimetric analysis 
and mass spectra were also consistent with the proposed formulation. The CD spectra of the 
enantiomers in water were equal and opposite (see ESI), and the compounds were found to be 
remarkably stable. At pH 7 and 20 °C, no significant hydrolysis was detected over weeks for 
RC,ΛFe,HHT-[Fe2L2a3]Cl4 and RC,ΛFe,HHT-[Fe2L3a3]Cl4, compared to Hannon’s cylinder36 
[Fe2(C25H20N4)3]Cl4 which in our hands decomposed far more rapidly. In strong acid (pH 1) the 
hydrolysis kinetics are cleanly first order and RC,ΛFe,HHT-[Fe2L2a3]Cl4 was recorded to have t1/2 of ca 
10.3 h, compared to 1.4 h for [Fe2(C25H20N4)3]Cl4. Remarkably RC,ΛFe,HHT-[Fe2L3a3]Cl4 is so stable 
to hydrolysis even at pH 1 that a half-life could not be recorded over 10 d. Furthermore, the 
compounds have excellent stability in the phosphate-rich RPMI-1640 cell growth medium over 96 h; 
for the same L2a and L3a compounds, 30% and 0% decay were observed, whereas [Fe2(C25H20N4)3]Cl4 
decomposed by ca 90%. 
Anticancer activity and mechanistic studies 
The sixteen new water-soluble Fe(II) triplex systems were screened, along with cisplatin for 
comparison, for their activity against cancer cell lines MDA-MB-468 (human breast adenocarcinoma) 
and HCT116 p53++ (human colon carcinoma with wild type p53). The latter was chosen following a 
recent report that FK-16 – a short amphipathic -helix derived from the human host-defence peptide 
LL-37 – induced apoptosis in a closely related cell-line.37  The resulting range of IC50 values indicated 
great selectivity, covering ca two orders of magnitude (0.5 – 70 µM) [Figs 3(a), (b)]. Notably, and in 
agreement with the stability studies above, no decolouration of the drug solutions was detected during 
the 96 h experiments. 
In MDA-MB-468 the L2 compounds have moderate toxicity and do not display enantiomeric 
selectivity; the nitroarene enantiomers (L2c) alone had similar activity to cisplatin. In contrast, all ΔFe-
L
3
 compounds are more active than their ΛFe enantiomers. Hydroxyl (L3b) or methoxy (L3c) 
functionality at position X reduces the observed activity ca 4-fold compared with the parent 
compound bearing L3a, whereas the benzyloxy (L3d) and pyrazine (L3e) compounds had similar 
activity. The same eight compounds as a group showed substantially higher activity against HCT116 
p53++, with several examples in the nanomolar range. Fe-L2 compounds are more active than the ΛFe 
enantiomers. Enantiomers of L3a and benzyloxy (L3d) compounds are up to seven times more potent 
than cisplatin while the others, noticeably the hydroxyl (L3b) are much less so.  
  
9 
 
(a) (b) 
  
(c) (d)  
 
 
Untreated control 
 
H2O2 
 
RC,ΛFe-[Fe2L2a3]Cl4 
 
RC,ΔFe-[Fe2L3a3]Cl4 
 
SC,ΔFe-[Fe2L2a3]Cl4 
 
SC,ΛFe-[Fe2L3a3]Cl4 
(e)    
 
Untreated control 
 
H2O2 
 
H2O2 and 
RC,ΛFe-[Fe2L2a3]Cl4  
H2O2 and 
RC,ΔFe-[Fe2L3a3]Cl4 
 
 
Fig 3 | Exposure of cancer cells to triplex metallohelices. IC50 values between 500 nM and 70 M following 96 h exposures at 37 °C and 
5 % CO2 against (a) human breast adenocarcinoma MDA-MB-468 showing modest toxicity cf. cisplatin and (b) human colon carcinoma 
HCT116 p53++ showing substantially higher and structure-dependent activity ; (c) Fluorescence-activated cell sorting assay showing the % 
population in stages of the cell cycle for untreated HCT116 p53++ cells and those exposed to RC,ΔFe,HHT-[Fe2L2a3]Cl4 and RC,ΛFe,HHT-
[Fe2L
3a
3]Cl4 (10 µM) for 24 h; (d) Comet assay analysis of DNA strand break induction in untreated HCT116 p53
++ cells and those exposed 
to hydrogen peroxide, HHT-[Fe2L
3a
3]Cl4 or HHT-[Fe2L
2a
3]Cl4 (10 µM) for 24 h; (e) Comet assay analysis of DNA cross link induction in 
untreated HCT116 p53++ cells and those exposed to hydrogen peroxide and HHT-[Fe2L
3a
3]Cl4 or HHT-[Fe2L
2a
3]Cl4 (10 µM) for 24 h. Errors 
shown are the calculated standard deviations from three repeats of each assay. 
Clinical anticancer treatments commonly include the use of DNA-binding or modifying drugs such as 
cisplatin. Such “alkylators” and DNA cleavage agents cause chemically irreversible reactions leading, 
in the absence of repair, to cell death.38,39 While the metal ions here are intended to be structure-
forming rather than reactive, and since some binding to naked calf thymus (ct-) DNA was detected by 
DNA melting (TM  +3 - 13 °C),  we sought to exclude the possibility of DNA damage. In a single 
cell gel electrophoresis assay, the absence of a ‘comet’ tail for HCT116 p53++ cells that had been 
treated with RC,Fe,HHT-[Fe2L2a3]Cl4 or RC,Fe,HHT-[Fe2L3a3]Cl4 indicates the absence of breaks 
(both single and double strand) and alkali labile sites. In a related test, triplexes also failed to retard 
the formation of comets in cells with deliberately strand-damaged DNA, consistent with the absence 
of cross linking activity. In addition, these compounds did not significantly alter the production of γ-
H2AX – a histone regarded as a universal marker for DNA damage.40  
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The accumulation of cancer cells in particular phases of the cell cycle can point to mode of 
action.41 Following incubation with triplex metallohelices10 µM, 24 h) and staining, HCT116 p53++ 
cells were analysed by fluorescence-activated cell sorting (FACS).41  Compared with control 
untreated cells, compound RC,ΔFe,HHT-[Fe2L3a3]Cl4 caused a dramatic increase in the proportion of 
cells in the G2/M phase (from ca 20 to 46% of cells) and sub G1 phase (ca 4 to 30%) and a 
corresponding reduction in G1 phase (ca 44 to 4%) and S phase (ca 29 to 9%). Cells in the sub G1 
phase are considered apoptotic42,43 and this data indicates that triplex helicates induce programmed 
cell death in HCT116 p53++ colon carcinoma cells. RC,ΛFe,HHT-[Fe2L2a3]Cl4 showed a similar but less 
extreme effect.  
 Given the high potency and substantial effects on the cancer cell cycle, we were very 
surprised to discover that enantiomers of the parent triplex compounds showed no signs of toxicity 
(bactericidal or inhibitory action) towards Methicillin-Resistant Staphylococcus aureus (MRSA - 
USA300) or Escherichia coli (TOP10) at up to the highest measured concentration of 128 g/ml i.e. 
two orders of magnitude higher than the recorded IC50 values against the cancer cell lines. 
 
Discussion 
A strategy for the selective formation of anti-parallel ‘triplex’ metallohelices has been successfully 
established though molecular modelling, synthetic and structural studies. Ultimately, while absolute 
configuration at the metal centres was achieved by conventional diastereoselection, the far greater 
challenge of selectivity for the target asymmetric HHT structure was achieved by maximisation of π-
stacking and other secondary interactions between ligands. Specifically, the relatively strong phenyl-
bpy -stacks and in some cases bifurcated C-H…O/N interactions are present only in the triplex 
architectures. This indicates how other new systems can be designed. These secondary interactions 
contribute also to chemical stability such that rates of hydrolysis in biologically-relevant media are 
exceptionally low. In addition, the modular self-assembly has allowed us to produce what we believe 
to be the largest and most diverse library of metallohelices to date. The potential recognition elements 
are arranged by the nature of the helix fold, and thereby via selection of molecular sub-component, a 
number of functional architectures can be made. We believe that this takes us a significant step 
towards -helix-peptide-like candidates for biochemical targets and phenotypic screens.  
To this end, and as with the peptidic -helices they are designed to emulate, triplex 
metallohelices have been shown to display potent, selective and structure-dependent toxicity to certain 
cancer cell-lines and – remarkably – no measured toxicity to example Gram positive and Gram 
negative bacteria. This is particularly striking given that our earlier symmetrical flexicate compounds 
inhibit bacterial growth at low concentrations.32 A subtle biomimetic mechanism rather than broad-
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spectrum cytotoxicity is thus indicated, and this is corroborated by the observation of major changes 
to the cell cycle without detected DNA damage. In future work we will establish whether an extrinsic 
or intrinsic pathway for apoptosis has been activated: do triplexes interact with membrane proteins or 
enter the cell and interfere with key internal pathways?  
The remarkable selectivity and stability, the unprecedented scope for structural variation, and the 
potent and selective activity suggest that triplex metallohelices may represent a new area of chemical 
space for the synthesis of novel pharmaceuticals. 
Methods 
Full details of computations, synthesis, characterisation and microbiological experiments are given in 
the Supplementary Information. Outlines of key procedures are detailed below.  
Molecular mechanics and DFT calculations 
Monometallic structures were first optimised using B3LYP-D3(BJ)44  functional and the 6-31g(d) 
basis set, with convergence criteria of 0.0001 a.u. as implemented in the Firefly quantum chemistry 
package,45 which is partially based on the GAMESS(US) source code.46  Bimetallic systems were 
optimised using ligand field molecular mechanics (LFMM)47 as implemented in the DommiMOE 
program,48  before being annealed at 500 K for 1 ns prior to re-optimisation. Single point energies 
were determined using the B3LYP-D3(BJ)44 functional and the def2-TZVP basis set.45  
Synthesis of water soluble triplex metallohelices 
Anhydrous iron(II) chloride (2 eq.) was add to a stirred solution of the either the desired chiral amine 
(3 eq.) and 5-(2,2'-bipyridin-5-ylmethoxy)picolinaldehyde (3 eq.) or the desired substituted aldehyde 
(3 eq.) and (R)-2-(2,2'-bipyridin-5-ylmethoxy)-1-phenylethanamine (3 eq.) in methanol (20 ml) at 
ambient temperature to give a purple solution that was then heated to reflux (65°C) for 24 – 48 h. The 
mixture was allowed to cool to ambient temperature, filtered through a celite plug and the solvents 
were removed in vacuo to give a dark purple solid (>95% yield). Water of crystallisation in these 
compounds was confirmed by NMR and IR spectroscopy. The hydration number was then determined 
by thermogravimetric analysis and the relevant mass loss was correlated with microanalytical data. 
NMR, IR and MS data were consistent with the proposed formulations. CD spectra of enantiomers in 
water were equal and opposite.  
Stability in aqueous media 
Visible absorbance spectra for stability studies were recorded using a Carey IE spectrometer. The 
intensity of the MLCT band (500-600 nm) of a 0.03 mM solution of each compound was measured 
over time in RPMI cell culture medium at 37°C, and also in 0.2 M hydrochloric acid at 20°C so that 
comparative t1/2 values for hydrolysis could be obtained. 
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Chemosensitivity (MTT assay) 
Cells were incubated in 96-well plates at a cell concentration of 2.0 × 104 cells/ml in RPMI-1640, 
supplemented with 10% foetal calf serum, sodium pyruvate (1 mM) and l-glutamine (2 mM). Plates 
were incubated for 24 h at 37°C in an atmosphere of 5% CO2, prior to drug exposure, then incubated 
for 96 h. 3-(4,5-Dimethylthiazol-1-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (0.5 mg/ml) 
was added to each well and incubated for a further 4 h. The IC50 values were determined from a plot 
of percentage cell survival against drug concentration (μM). All assays were conducted in triplicate 
and the mean IC50 ± standard deviation was determined.  
-H2AX assay 
In triplicate, and against untreated control cells, drug-treated HCT116 wild type p53 cells were 
washed twice in incubation buffer (PBS containing BSA) then re-suspended. Primary rabbit anti-
human phosphor Histone H2AX (Ser 139) antibody (1:50 final dilution) was added and incubated at 
RT for 1 h before treatment with Alexa Fluor conjugated anti-rabbit IgG secondary antibody (1:1000 
final dilution) and incubation for 30 min before fluorescence activated cell sorting (FACS).  
Cell cycle assay 
300 µl PBS containing Propidium Iodide (40 µg/ml) and RNAse A (200µg/ml) was added to drug-
treated cells before incubation for 30 min and FACS analysis. The  assay was repeated four times with 
each compound and the mean % cells in each phase ± standard deviation was determined. Red 
fluorescence was observed at 488nm excitation by flow cytometry and data analysed using 
WinMDI2.9 and Cylchred software.  
Single cell gel electrophoresis (comet) assays 
Cells were seeded in complete RPMI-1640 medium and incubated, then treated with drug (10 µM, 24 
h), washed, harvested and embedded in agarose. Following horizontal gel electrophoresis (25 min) the 
slides were stained with SYBRTM Gold solution (Molecular probes Inc.) and viewed with an 
epifluorescent microscope (Nikon Eclipse E800, Japan). The tail moment was measured on 50 
randomly selected cells using Comet assay III software (Perceptive Instruments, UK). Each assay was 
performed in triplicate.  
Antimicrobial Experiments 
The standardised macrobroth dilution method49 in cation-adjusted Mueller-Hinton broth was used. 
Bacterial growth was monitored over 20 h at 37 °C with an iEMS 96-well plate reader. The lowest 
concentration to inhibit growth across each repeat is classified as the MIC. Positive (medium and 
untreated bacteria) and negative (medium only) controls were run with each plate. The antimicrobial 
properties of our recently reported flexicate systems32 were reproduced as a positive control, alongside 
ampicillin.  
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Figure Legends & Tables 
Figure 1 | Metallohelix architectures.  
Figure 2 | Synthesis and characterisation of triplex metallohelices.  
Figure 3 | Exposure of cancer cells to triplex metallohelices.  
Table 1 | Calculated energies (DFT) of selected isomers for monometallic units and 
metallohelices.  
  
15 
 
References 
1 Zanetti, M., Gennaro, R. & Romeo, D. Cathelicidins: a novel protein family with a common 
proregion and a variable C-terminal antimicrobial domain. FEBS Letters 374, 1-5, (1995). 
2 Lane, D. P. p53, guardian of the genome. Nature 358, 15-16, (1992). 
3 Dürr, U. H. N., Sudheendra, U. S. & Ramamoorthy, A. LL-37, the only human member of the 
cathelicidin family of antimicrobial peptides. Biochimica et Biophysica Acta (BBA) - 
Biomembranes 1758, 1408-1425, (2006). 
4 Wu, W. K. K. et al. Emerging roles of the host defense peptide LL-37 in human cancer and its 
potential therapeutic applications. International Journal of Cancer 127, 1741-1747, (2010). 
5 Baker, S. J. et al. Chromosome 17 Deletions and p53 Gene Mutations in Colorectal 
Carcinomas. Science 244, 217-221, (1989). 
6 Takahashi, T. et al. p53: A Frequent Target for Genetic Abnormalities in Lung Cancer. Science 
246, 491-494, (1989). 
7 Walensky, L. D. et al. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix. 
Science 305, 1466-1470, (2004). 
8 Gavathiotis, E. et al. BAX activation is initiated at a novel interaction site. Nature 455, 1076-
1081, (2008). 
9 Cheng, R. P., Gellman, S. H. & DeGrado, W. F. beta-peptides: From structure to function. 
Chemical Reviews 101, 3219-3232, (2001). 
10 Appella, D. H., Christianson, L. A., Karle, I. L., Powell, D. R. & Gellman, S. H. beta-peptide 
foldamers: Robust Helix formation in a new family of beta-amino acid oligomers. Journal of 
the American Chemical Society 118, 13071-13072, (1996). 
11 Johnson, L. M. & Gellman, S. H. in Methods in Protein Design Vol. 523 Methods in 
Enzymology (ed A. E. Keating)  407-429 (2013). 
12 Davis, J. M., Tsou, L. K. & Hamilton, A. D. Synthetic non-peptide mimetics of alpha-helices. 
Chem. Soc. Rev. 36, 326-334, (2007). 
13 Azzarito, V., Long, K., Murphy, N. S. & Wilson, A. J. Inhibition of [alpha]-helix-mediated 
protein-protein interactions using designed molecules. Nat Chem 5, 161-173, (2013). 
14 Lehn, J. M. et al. Spontaneous assembly of double-stranded helicates from oligobipyridine 
ligands and copper(I) cations: structure of an inorganic double helix. Proc. Natl. Acad. Sci. 
U.S.A. 84, 2565-2569, (1987). 
15 Albrecht, M. & Fröhlich, R. Controlling the Orientation of Sequential Ligands in the Self-
Assembly of Binuclear Coordination Compounds. J. Am. Chem. Soc. 119, 1656-1661, (1997). 
16 Torelli, S., Delahaye, S., Hauser, A., Bernardinelli, G. & Piguet, C. Ruthenium(II) as a novel 
labile partner in thermodynamic self-assembly of heterobimetallic d-f triple-stranded 
helicates. Chem. Eur. J. 10, 3503-3516, (2004). 
17 Hahn, F. E., Schulze Isfort, C. & Pape, T. A dinuclear, triple-stranded helicate with a diamide-
bridged catechol/benzenedithiol ligand. Angewandte Chemie 43, 4807-4810, (2004). 
18 Rice, C. R., Baylies, C. J., Jeffery, J. C., Paul, R. L. & Ward, M. D. Mononuclear Cu(II) and triple 
helical dinuclear Co(II) complexes of a new potentially tetradentate ligand containing 
inequivalent bidentate units. Inorganica Chimica Acta 324, 331-335, (2001). 
19 Hannon, M. J., Bunce, S., Clarke, A. J. & Alcock, N. W. Spacer Control of Directionality in 
Supramolecular Helicates Using an Inexpensive Approach. Angewandte Chemie International 
Edition 38, 1277-1278, (1999). 
20 Constable, E. C., Heirtzler, F. R., Neuburger, M. & Zehnder, M. Directional ligands in helicate 
selfassembly. Supramol. Chem. 5, 197-200, (1995). 
21 Albrecht, M., Napp, M., Schneider, M., Weis, P. & Frohlich, R. Kinetic thermodynamic control 
of the self-assembly of isomeric double-stranded dinuclear titanium() complexes from a 
phenylalanine-bridged dicatechol ligand. Chemical Communications, 409-410, (2001). 
16 
 
22 Schulze Isfort, C., Kreickmann, T., Pape, T., Frohlich, R. & Hahn, F. E. Helical complexes 
containing diamide-bridged benzene-o-dithiolato/catecholato ligands. Chemistry 13, 2344-
2357, (2007). 
23 Howson, S. E. & Scott, P. Approaches to the synthesis of optically pure helicates. Dalton 
Trans. 40, 10268-10277, (2011). 
24 Kerckhoffs, J. M. C. A. et al. Enantiomeric resolution of supramolecular helicates with 
different surface topographies. Dalton Trans., 734-742, (2007). 
25 Hotze, A. C. G. et al. Supramolecular iron cylinder with unprecedented DNA binding is a 
potent cytostatic and apoptotic agent without exhibiting genotoxicity. Chem. Biol. 15, 1258-
1267, (2008). 
26 Cardo, L., Sadovnikova, V., Phongtongpasuk, S., Hodges, N. J. & Hannon, M. J. Arginine 
conjugates of metallo-supramolecular cylinders prescribe helicity and enhance DNA junction 
binding and cellular activity. Chem. Commun. 47, 6575-6577, (2011). 
27 Yu, H. et al. Metallosupramolecular complex targeting an a/b discordant stretch of amyloid b 
peptide. Chem. Sci. 3, 3145-3153, (2012). 
28 Howson, S. E. et al. Origins of stereoselectivity in optically pure phenylethaniminopyridine 
tris-chelates M(NN')3
n+
 (M = Mn, Fe, Co, Ni and Zn). Dalton Trans. 40, 10416-10433, (2011). 
29 Howson, S. E. et al. Self-assembling optically pure Fe(A-B)3 chelates. Chem. Commun. 0, 
1727-1729, (2009). 
30 Howson, S. E. et al. Jahn-Teller effects on p-stacking and stereoselectivity in the 
phenylethaniminopyridine tris-chelates Cu(NN')3
2+
. Dalton Trans. 41, 4477-4483, (2012). 
31 Howson, S. E. et al. Optically pure heterobimetallic helicates from self-assembly and click 
strategies. Dalton Transactions 42, 14967-14981, (2013). 
32 Howson, S. E. et al. Optically pure, water-stable metallo-heliĐal ͚fleǆiĐate͛ asseŵďlies ǁith 
antibiotic activity. Nat. Chem. 4, 31-36, (2012). 
33 Brabec, V. et al. Metallohelices with activity against cisplatin-resistant cancer cells; does the 
mechanism involve DNA binding? Chemical Science, (2013). 
34 Hunter, C. A. & Sanders, J. K. M. The nature of .pi.-.pi. interactions. J. Am. Chem. Soc. 112, 
5525-5534, (1990). 
35 Griŵŵe, “. Do “peĐial NoŶĐoǀaleŶt π–π “taĐkiŶg IŶteraĐtioŶs ‘eallǇ Eǆist? Angewandte 
Chemie International Edition 47, 3430-3434, (2008). 
36 Hannon, M., J. , Painting, C., L. , Jackson, A., Hamblin, J. & Errington, W. An inexpensive 
approach to supramolecular architecture. Chem. Commun., 1807-1808, (1997). 
37 Ren, S. X. et al. FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-
Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells. PLoS ONE 8, 
e63641, (2013). 
38 Fu, D., Calvo, J. A. & Samson, L. D. Balancing repair and tolerance of DNA damage caused by 
alkylating agents. Nat. Rev. Cancer 12, 104-120, (2012). 
39 Siddik, Z. H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 
22, 7265-7279, (2003). 
40 Bonner, W. M. et al. [gamma]H2AX and cancer. Nat Rev Cancer 8, 957-967, (2008). 
41 Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide 
staining. The Journal of Cell Biology 66, 188-193, (1975). 
42 Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. & Riccardi, C. A rapid and simple 
method for measuring thymocyte apoptosis by propidium iodide staining and flow 
cytometry. Journal of Immunological Methods 139, 271-279, (1991). 
43 Kajstura, M., Halicka, H. D., Pryjma, J. & Darzynkiewicz, Z. Discontinuous fragmentation of 
ŶuĐlear DNA duriŶg apoptosis reǀealed ďǇ disĐrete ͞suď-G1͟ peaks oŶ DNA ĐoŶteŶt 
histograms. Cytometry Part A 71A, 125-131, (2007). 
44 Grimme, S., Ehrlich, S. & Goerigk, L. Effect of the damping function in dispersion corrected 
density functional theory. Journal of Computational Chemistry 32, 1456-1465, (2011). 
17 
 
45 Granovsky, A. A. Firefly version 7.1.G, http://classic.chem.msu.su/gran/firefly/index.html. 
46 Schmidt, M. W. et al. General atomic and molecular electronic structure system. Journal of 
Computational Chemistry 14, 1347-1363, (1993). 
47 Deeth, R. J., Anastasi, A., Diedrich, C. & Randell, K. Molecular modelling for transition metal 
complexes: Dealing with d-electron effects. Coord. Chem. Rev. 253, 795-816, (2009). 
48 Deeth, R. J., Fey, N. & Williams–Hubbard, B. DommiMOE: An implementation of ligand field 
molecular mechanics in the molecular operating environment. J. Comput. Chem. 26, 123-
130, (2005). 
49 Andrews, J. M. Determination of minimum inhibitory concentrations. Journal of 
Antimicrobial Chemotherapy 48, 5-16, (2001). 
50 Coles, S. J. & Gale, P. A. Changing and challenging times for service crystallography. Chemical 
Science 3, 683-689, (2012). 
 
